Long-Term Efficacy and Safety of CT-P10 in Patients With RA
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This is an open-label, single-arm, multicenter, efficacy, and safety maintenance study of the
Phase 1 Study CT-P10 1.1. This study is designed to assess the long-term efficacy and safety
of CT-P10 co-administered with MTX and folic acid in patients with RA who have completed the
scheduled visits in Study CT-P10 1.1